Summary
- Top of page
- Summary
- Introduction
- Results
- Discussion
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
Large, long-lived species experience more lifetime cell divisions and hence a greater risk of spontaneous tumor formation than smaller, short-lived species. Large, long-lived species are thus expected to evolve more elaborate tumor suppressor systems. In previous work, we showed that telomerase activity coevolves with body mass, but not lifespan, in rodents: telomerase activity is repressed in the somatic tissues of large rodent species but remains active in small ones. Without telomerase activity, the telomeres of replicating cells become progressively shorter until, at some critical length, cells stop dividing. Our findings therefore suggested that repression of telomerase activity mitigates the increased risk of cancer in larger-bodied species but not necessarily longer-lived ones. These findings imply that other tumor suppressor mechanisms must mitigate increased cancer risk in long-lived species. Here, we examined the proliferation of fibroblasts from 15 rodent species with diverse body sizes and lifespans. We show that, consistent with repressed telomerase activity, fibroblasts from large rodents undergo replicative senescence accompanied by telomere shortening and overexpression of p16Ink4a and p21Cip1/Waf1 cycline-dependent kinase inhibitors. Interestingly, small rodents with different lifespans show a striking difference: cells from small shorter-lived species display continuous rapid proliferation, whereas cells from small long-lived species display continuous slow proliferation. We hypothesize that cells of small long-lived rodents, lacking replicative senescence, have evolved alternative tumor-suppressor mechanisms that prevent inappropriate cell division in vivo and slow cell growth in vitro. Thus, large-bodied species and small but long-lived species have evolved distinct tumor suppressor mechanisms.
Introduction
- Top of page
- Summary
- Introduction
- Results
- Discussion
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
Replicative senescence was first described in human cells over 40 years ago (Hayflick & Moorhead, 1961). The major mechanism underlying replicative senescence is progressive telomere shortening, which occurs with every cell division in cells lacking telomerase activity (Harley et al., 1990; Shay & Wright, 2000). Replicative senescence is thought to be an antitumor mechanism that limits cell proliferation (Campisi, 2001; Sedivy, 2007) and contributes to long cancer-free human lifespan. Replicative senescence also occurs in the fibroblasts of several nonhuman primates (Steinert et al., 2002; Herbig et al., 2006; Gardner et al., 2007), and large farm animals such as cow (Hornsby et al., 1986), sheep (Davis et al., 2005), and horse (Argyle et al., 2003), (reviewed in Davis & Kipling, 2005; Gorbunova & Seluanov, 2008). But we still know little about senescence, or the lack thereof, in other mammalian species.
Senescence of mouse cells differs from replicative senescence of human cells in many ways (Sedivy, 1998; Wright & Shay, 2000; Parrinello et al., 2003). First, mouse somatic cells express telomerase and have very long telomeres (Prowse & Greider, 1995). Second, when cultured under 20% oxygen, mouse fibroblasts slow their growth after approximately ten population doublings (PDs), but after a few days immortal clones emerge and continue rapid growth (Parrinello et al., 2003). Such spontaneous immortalization does not occur in cultures of human fibroblasts (Wright & Shay, 2000). Third, under physiological oxygen concentration, mouse fibroblasts do not display senescent phenotype (Parrinello et al., 2003). Thus, ‘senescence’ of mouse cells appears to be a stress response, which is more akin to stress-induced premature senescence than replicative senescence (Sherr & DePinho, 2000; Wright & Shay, 2000; Parrinello et al., 2003).
The difference in telomere biology between humans and mice is intriguing. We recently undertook a study aiming to understand the evolutionary basis of this difference. To test the hypothesis that somatic repression of telomerase activity might have evolved as a tumor-suppressor adaptation in large or long-lived species, we analyzed telomerase activity in fresh tissues of 15 rodent species with diverse lifespans and body masses (Seluanov et al., 2007). Our comparative analysis showed that telomerase activity coevolves with body mass but not lifespan. The largest rodents, capybara and beaver, showed a near complete repression of telomerase activity, as in humans. In contrast, all small rodents showed high levels of telomerase activity in somatic tissues. Surprisingly, telomerase activity was detected in somatic tissues of both short- and long-lived small species, including the longest-lived rodents, the naked mole-rat and the Eastern gray squirrel.
Here we address several questions raised by our previous study. First, does the repression of telomerase activity in the somatic tissues of large rodents mean that their fibroblasts will display replicative senescence? Second, the presence of telomerase activity in somatic tissues of small long-lived rodents is puzzling: these animals remain largely tumor-free during their long lives despite the increased cancer risk of persistent telomerase activity. We therefore asked if fibroblasts from these species display the same rapid proliferation in culture as fibroblasts from short-lived, cancer-prone mice.
To answer these questions we studied replicative lifespan of fibroblasts from 15 rodent species. First, we show that fibroblasts from large rodent species that lack telomerase activity enter typical replicative senescence, as expected. Second, we demonstrate that fibroblasts from small short-lived rodent species maintaining telomerase activity lack replicative senescence, and display rapid continuous growth. Last, and most surprising, we show that fibroblasts from small long-lived rodents also lack replicative senescence and instead display unusually slow growth. We hypothesize that cells of small long-lived rodents have evolved alternative tumor-suppressor mechanisms – ones distinct from regulation of telomerase activity – that protect them from cancer in vivo and slow their proliferation in vitro.
Discussion
- Top of page
- Summary
- Introduction
- Results
- Discussion
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
Our study shows that fibroblast growth characteristics have coevolved with species body mass and lifespan. Previously, we showed that repression of telomerase activity in rodent tissues coevolves with large body mass in rodents (Seluanov et al., 2007). Here we extend these observations to include a correlation between larger body mass and the presence of replicative senescence: the largest rodents – beaver, capybara, porcupine, and paca – have evolved replicative senescence (Fig. 8). The sizes of these species suggest that, to the level of resolution of our study, body mass greater than 8000 g favors the evolution of replicative senescence (Fig. 1). Evolutionary increases in body mass increase cancer risk, as larger animals contain more cells in their body, and any cell may potentially turn cancerous. Increased mortality rate due to cancer then drives the adaptive evolution of repression of telomerase activity in species with large body mass. It has been predicted that larger animals should have multiple, redundant tumor-suppressor systems so that their cells require more steps for tumor formation (Graham, 1983; Nunney, 1999; Leroi et al., 2003). Our data on rodents provide experimental support for this theory.
Our study is focused exclusively on rodent species and it remains unclear if the same rules apply to other groups of mammals. Telomere biology in mammals studied so far supports the model of coevolution of replicative senescence and body mass (reviewed in Gorbunova & Seluanov, 2008). For instance, large mammals such as cow, sheep, and horse do not express telomerase in somatic tissues, and their fibroblasts have finite lifespan in culture (Hornsby et al., 1986; Argyle et al., 2003; Davis et al., 2005). Replicative senescence has also been documented in large primates such as chimpanzee, orangutan, gorilla, baboon, and several macaque species (Steinert et al., 2002; Herbig et al., 2006; Gardner et al., 2007). An intermediate situation where fibroblasts do not express telomerase activity but their cultures fail to undergo growth arrest has been detected in smaller species, such as rabbits and the ring-tailed lemur (Steinert et al., 2002; Forsyth et al., 2005). A general trend seems to be that mammals with a body mass greater than 8000 g evolve stringent replicative senescence, mammals smaller than 2000 g do not use replicative senescence, and species with body mass between 2000 and 8000 g display a spectrum of intermediate phenotypes.
Even less is known about telomere biology in birds. Long-lived species, such as the storm petrel and common tern, express telomerase throughout their lives (Haussmann et al., 2007). Both of these species are small with an adult body mass below 200 g. Telomerase activity has also been detected in the somatic tissues of a larger bird, the domestic chicken (Venkatesan & Price, 1998). However, chicken fibroblasts do not express telomerase and undergo a clear-cut replicative senescence (Ponten, 1970; Dinowitz, 1977). Little is known about telomere biology in the largest bird species such as ostrich or emperor penguin. The number of PDs before senescence has been correlated to maximum lifespan (Rohme, 1981), or when phylogenetic correction was applied, to species body mass (Lorenzini et al., 2005). Our data set does not allow for such analysis as only four species undergo replicative senescence with three of them showing similar replicative lifespans.
Long lifespan, like body mass, is expected to increase cancer risk. It may therefore seem puzzling that the long-lived rodents in our study have not evolved replicative senescence. While being a potent tumor suppressor, replicative senescence has many tradeoffs, such as slower wound healing and less robust immune response. Furthermore, replicative senescence is only one of many possible tumor-suppressor mechanisms, and it is plausible that these species rely on other mechanisms to mitigate the cancer risk conferred by their long lifespan. Indeed we found that fibroblasts of small, long-lived species such as gray squirrel, naked mole-rat, chinchilla, musk-rat, and chipmunk exhibit a novel in vitro phenotype: their cells do not enter replicative senescence but instead proliferate slowly in culture (Fig. 8). We show that, for small rodent species that have not evolved replicative senescence, in vitro fibroblast proliferation rate negatively correlates with longevity. We hypothesize that the slow in vitro growth rate is a manifestation of those alternative tumor suppressor mechanisms that evolve in small, long-lived species lacking replicative senescence (Fig. 8).
Interestingly, embryonic squirrel fibroblasts, proliferated rapidly up to PD30, after which the culture slowed down and attained the adult growth phenotype. Thus, the growth control mechanisms that restrict proliferation of squirrel cells are characteristic of an adult but not embryonic cells. This scenario is reminiscent of the repression of hTERT expression during human embryonic development. Telomerase is expressed in early embryogenesis, but its expression is progressively shut off in later development (Bekaert et al., 2004). Thus, the mechanisms that restrict proliferation of somatic cells are inactive during early development when they would otherwise interfere with rapid cell division.
In vitro culture forces cells to proliferate under nonphysiological conditions. In vivo, the majority of cells in adult tissues are nondividing. When placed in culture, cells are stimulated to divide by mitogens provided by fetal serum. The ability of cells to proliferate in culture dishes can be considered a measure of their tumorigenic potential. We hypothesize that long-lived rodents evolve mechanisms that make their cells acutely sensitive to any environmental or physiological imbalances, and arrest cell proliferation in inappropriate conditions. The same mechanisms will prevent inappropriate cell division in vivo, protecting the organism from tumor growth and metastasis.
What are the potential cues that slow proliferation of adult fibroblasts of small long-lived rodents? Perhaps, it could be unrestrained mitogenic stimulation, disrupted cell–cell contacts, sensitivity to DNA damage, or some other as yet undetermined cue. It seems likely that these proliferation control mechanisms differ among species because, as can be inferred from rodent phylogeny (Fig. 1), they have evolved with slow aging independently at least three times. In-depth studies of the individual small long-lived species are required to understand the molecular mechanisms responsible for the different anticancer adaptations that have evolved among them.
In summary, our analysis of fifteen rodent species has uncovered an intricate picture of how increased cancer risk conferred by large body mass or long lifespan drives evolution of tumor suppressor mechanisms (Fig. 8). Body mass has previously been linked to the evolution of several characteristics such as repression of telomerase activity (Seluanov et al., 2007), more efficient DNA repair (Promislow, 1994), and the number of PDs before senescence (Lorenzini et al., 2005). Here we show that both body mass and lifespan contribute to the evolution of tumor suppressor mechanisms, but in two different ways. Large body mass coevolved with replicative senescence, while long lifespan is associated with evolution of alternative mechanisms that increase the sensitivity of the cells to growth conditions and slow cell proliferation in culture.
Supporting Information
- Top of page
- Summary
- Introduction
- Results
- Discussion
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
Fig. S1 Comparison of telomere biology and cell growth kinetics in wild-caught and laboratory mice and rats. (A) Telomerase activity examined by TRAP assay in early and late passage fibroblasts. (B) Telomere length analyzed by terminal restriction fragment assay. (C) Growth curves of primary fibroblasts. Mouse and rat averages (Fig. 2B) are compared to the individual growth curves of the wild-caught mouse and rat. LF and SF correspond to lung and skin fibroblasts, respectively.
Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing material) should be directed to the Aging Cell Central Office.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.